Internal Medicine, Hematology & Oncology · Holland, MI
NPI
1821126830
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
12460 Riley St
Holland, MI, 49424
Phone (616) 399-6500
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
126,827 services
Medicare patients, 2024
436
Average age 74
Drug cost, 2024
$15.3M
5,135 prescriptions
Company payments, 2025
$1,828
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eric D Batts was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 2,592 times for 50 patients. In total Eric D Batts billed 126,827 services in 184 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,592 | 50 | $0.09 | $231 |
| 36415 Venipuncture Blood Collection | Office | 1,382 | 235 | $8.64 | $12K |
| 85025 Blood Count | Office | 1,335 | 226 | $7.59 | $10K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,150 | 20 | $0.70 | $806 |
| 80053 Clinical Chemistry | Office | 1,097 | 218 | $10.31 | $11K |
| J9190 Injection, fluorouracil, 500 mg | Office | 727 | 11 | $2.26 | $1,644 |
| 96375 Injection Administration | Office | 546 | 62 | $10.86 | $5,929 |
| 99214 Office E&M - Established | Office | 423 | 204 | $89.17 | $38K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 384 | 57 | $138.33 | $53K |
| 96413 Chemotherapy Administration | Office | 371 | 62 | $91.10 | $34K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 291 | 32 | $4.91 | $1,429 |
| 84153 Clinical Chemistry | Office | 222 | 73 | $17.96 | $3,987 |
| 99213 Office E&M - Established | Office | 182 | 144 | $55.92 | $10K |
| 82784 Immunoassay | Office | 180 | 26 | $9.11 | $1,640 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 176 | 52 | $71.27 | $13K |
By year: 2022 $1.9M for 118,856 services; 2023 $1.5M for 144,040 services; 2024 $2.1M for 126,827 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,382 | 235 | $8.64 | $12K |
| 85025 Blood Count | 1,335 | 226 | $7.59 | $10K |
| 80053 Clinical Chemistry | 1,097 | 218 | $10.31 | $11K |
| 84153 Clinical Chemistry | 222 | 73 | $17.96 | $3,987 |
| 82784 Immunoassay | 180 | 26 | $9.11 | $1,640 |
| 83615 Clinical Chemistry | 133 | 56 | $5.89 | $783 |
| 83521 Immunoassay | 114 | 25 | $16.93 | $1,929 |
| 82728 Clinical Chemistry | 105 | 33 | $13.26 | $1,392 |
| 83735 Clinical Chemistry | 102 | 25 | $6.52 | $665 |
| 84443 Clinical Chemistry | 90 | 34 | $16.46 | $1,481 |
Medicare prescription drug claims, 2024
In 2024, the drug Eric D Batts prescribed most often to Medicare patients was Prednisone, with 669 prescriptions and refills. In total Eric D Batts wrote 5,135 Medicare prescriptions that cost $15.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 669 | 743 | 133 | $2,598 |
| Abiraterone Acetate Generic | 498 | 498 | 79 | $1.5M |
| Acyclovir Generic | 309 | 392 | 63 | $4,359 |
| Anastrozole Generic | 297 | 687 | 77 | $9,008 |
| Prochlorperazine Maleate Generic | 167 | 167 | 86 | $2,321 |
| Imbruvica Ibrutinib | 161 | 161 | 14 | $2.3M |
| Hydroxyurea Generic | 156 | 275 | 28 | $3,450 |
| Xtandi Enzalutamide | 145 | 145 | 32 | $1.2M |
| Letrozole Generic | 137 | 382 | 42 | $4,529 |
| Levothyroxine Sodium Generic | 120 | 161 | 22 | $1,145 |
| Potassium Chloride Generic | 120 | 134 | 31 | $1,876 |
| Eliquis Apixaban | 85 | 99 | 21 | $54K |
| Allopurinol Generic | 83 | 125 | 26 | $1,064 |
| Venclexta Venetoclax | 78 | 78 | 16 | $744K |
| Revlimid Lenalidomide | 76 | 76 | 16 | $1.3M |
Brand drugs: - claims; generic drugs: 3,975 claims; opioid claims: 100.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eric D Batts $1,828 ($1,828 in general payments such as food, travel and fees) from 35 companies. The largest payer was Novartis Pharmaceuticals Corporation with $182.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 9 | $182 |
| GlaxoSmithKline, LLC. GSK | 6 | $125 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $103 |
| Telix Pharmaceuticals TLX | 1 | $100 |
| Daiichi Sankyo Inc. 4568.T | 4 | $98.52 |
| Pfizer Inc. PFE | 5 | $96.35 |
| Merck Sharp & Dohme LLC MRK | 3 | $90.08 |
| Eisai Inc. 4523.T | 3 | $86.77 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $84.24 |
| Abbvie Inc. ABBV | 4 | $68.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.